🇺🇸 FDA
Patent

US 11433118

Long-acting VEGF inhibitors for intraocular neovascularization

granted A61KA61K38/179A61K39/001109

Quick answer

US patent 11433118 (Long-acting VEGF inhibitors for intraocular neovascularization) held by The Regents of the University of California expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/179, A61K39/001109, A61K9/0019, A61K9/0048